Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets

Eriko Yamada, Maria Montoya, Christian G. Schuettler, Timothy P. Hickling, Alexander W. Tarr, Alessandra Vitelli, Jean Dubuisson, Arvind H. Patel, Jonathan Ball, Persephone Borrow

Research output: Contribution to journalArticlepeer-review

29 Citations (Scopus)

Abstract

Hepatitis C virus (HCV) binding to hepatocytes is thought to be mediated via interaction of the E2 glycoprotein with (co-)receptors including CD81 and scavenger receptor class B type I (SR-BI). Here, the expression of CD81 and SR-BI was analysed on peripheral blood mononuclear cell (PBMC) subsets, and the binding of genotype 1 soluble truncated E2 (sE2) proteins to these cells was investigated. All PBMC subsets expressed CD81, although at varying levels. In contrast, SR-BI was only detected on monocytes and dendritic cells (DCs). The genotype 1a H77c sE2 protein showed higher PBMC binding than other genotype 1a/b sE2s. H77c sE2 binding to different PBMC subsets largely paralleled their level of CD81 expression, and could be inhibited by blocking E2-CD81 interaction. However, those PBMC subsets reported to be infected by HCV in vivo (monocytes, DCs and B cells) also exhibited residual, CD81-independent binding, indicating roles for SIR-BI/other receptor(s) in mediating haematopoietic cell infection.
Original languageEnglish
Pages (from-to)2507-2512
Number of pages6
JournalJournal of General Virology
Volume86
Issue number9
DOIs
Publication statusPublished - 1 Sept 2005
Externally publishedYes

Fingerprint

Dive into the research topics of 'Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets'. Together they form a unique fingerprint.

Cite this